| Market Cap | ₹6,425Cr |
| ROE | 23.91% |
| P/E Ratio(TTM) | 47.33 |
| EPS(TTM) | 8.53 |
| P/B Ratio | 12.03 |
| Dividend Yield | 1.73% |
| Industry P/E | 56.37 |
| Book Value | 33.57 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Managing Director | Mr. Rahul Guha |
| Founded | 1996 |
| NSE Symbol | THYROCARE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 45.34 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 68.60 | ||
| Metropolis Healthcare | NA (0.00%) | 61.06 | ||
| Krsnaa Diagnostics | NA (0.00%) | 27.36 |